← Back to Search

Behavioural Intervention

Dyadic-FIT condition (DFIT) for Smoking/Cigarette Smoking

N/A
Recruiting
Led By Michelle R vanDellen, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial aims to study the effectiveness of financial incentives for smoking cessation in dual-smoker couples (DSCs). DSCs are less likely to try to quit smoking and more likely to relapse

Who is the study for?
This trial is for couples where both partners smoke cigarettes. They must be willing to try quitting together and participate in a study that involves financial incentives as motivation. Specific eligibility details are not provided, but typically participants would need to meet certain health criteria and commit to the study's schedule.Check my eligibility
What is being tested?
The trial tests two versions of Financial Incentive Treatments (FITs) designed to help dual-smoker couples quit smoking. Participants will receive usual care plus potential cash rewards for abstaining from smoking at set intervals. One group gets incentives just for one partner, while the other group has both partners receiving incentives.See study design
What are the potential side effects?
Since this trial involves financial incentives rather than medical treatments or drugs, there aren't traditional side effects like you'd expect with medication. However, stress or tension could arise from trying to quit smoking, especially under a structured program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Point-Prevalence Abstinence at End of Treatment
Secondary outcome measures
Partner Point-Prevalence Abstinence
Point-Prevalence Abstinence After Treatment
Point-Prevalence Abstinence at First Follow-up
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Single-Target FIT (SFIT)Experimental Treatment1 Intervention
One couple member offered incentives. Targets in the SFIT condition will be offered financial incentives for biochemically verified abstinence ($200 at each of three follow-ups [1, 3, and 6 Month]).
Group II: Dyadic-FIT condition (DFIT)Experimental Treatment1 Intervention
Both couple members offered incentives and tracked across 12 months. Both targets and partners will be offered financial incentives for abstinence. Thus, in this condition, the total financial incentives offered to the dyad are twice the amount as offered to participants in the SFIT condition.
Group III: No-FIT Treatment-as-Usual (TAU) ConditionActive Control1 Intervention
Participants in the no-FIT control condition will not receive incentives.

Find a Location

Who is running the clinical trial?

University of GeorgiaLead Sponsor
102 Previous Clinical Trials
33,862 Total Patients Enrolled
McMaster UniversityOTHER
884 Previous Clinical Trials
2,597,416 Total Patients Enrolled
University of KentuckyOTHER
186 Previous Clinical Trials
225,784 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers actively seeking participants for this ongoing clinical trial?

"Yes, the details on clinicaltrials.gov imply that this study is currently open for enrollment. The trial was originally listed on January 18th, 2024 and had its most recent update on February 29th, 2024. This investigation aims to recruit a total of 900 participants at one designated site."

Answered by AI
~600 spots leftby May 2028